A 37-year-old man is in the clinic today for worsening shortness of breath. He first noticed decreasing activity tolerance at age 28, at which time an x-ray revealed some hyperinflation consistent with mild emphysema. He had been smoking one pack of cigarettes per day since age 15 and quit at age 28. However, his shortness of breath has continued to progress. Physical examination reveals a thin man in moderate respiratory distress. There is a marked increase in the anteroposterior diameter, distant lung sounds, and occasional expiratory wheeze. Blood gases on room air are as follows: pH 7.42, PaCO2 40, PaO2 71, HCO3 – 26. PFT results are as follows:
Predicted Normal
Pre-bronchodilator Percentage of Predicted
Post-bronchodilator Percentage of Predicted
FEV1
3.8 L
16
18
FVC
4.8 L
29
35
FEV1/FVC
>70%
44
40
TLC
7 L
130
130
In view of the pre- and post-bronchodilator data, does he have airways that are likely to respond to β2-agonist drug therapy?